MAM
ESPR

Meeder Asset Management’s Esperion Therapeutics ESPR Stock Holding History

Meeder Asset Management’s Portfolio ESPR Stock Details ESPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2,942
Closed -$6.47K – 948
2024
Q4 		$6.47K Buy
+2,942
New +$6.86K ﹤0.01% 787
2020
Q2 		– Sell
-580
Closed -$18K – 2167
2020
Q1 		$18K Buy
+580
New +$30.6K ﹤0.01% 1280
2019
Q1 		– Sell
-98
Closed -$5K – 1741
2018
Q4 		$5K Buy
+98
New +$4.72K ﹤0.01% 1405
2018
Q2 		– Sell
-404
Closed -$30K – 1592
2018
Q1 		$30K Buy
404
+33
+9% +$2.42K ﹤0.01% 783
2017
Q4 		$25K Buy
371
+114
+44% +$6.14K ﹤0.01% 869
2017
Q3 		$13K Buy
257
+158
+160% +$7.62K ﹤0.01% 1011
2017
Q2 		$5K Sell
99
-15
-13% -$552 ﹤0.01% 1188
2017
Q1 		$4K Sell
114
-2,842
-96% -$65.1K ﹤0.01% 1153
2016
Q4 		$37K Buy
+2,956
New +$35.2K ﹤0.01% 591

Other funds holding ESPR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
PCM
PenderFund Capital Management Vancouver, British Columbia, Canada $639M AUM 31.05% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return